Ammar M. Almaaytah
Irbid, IR 22110, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Design and Efficacy of an Ultrashort Antimicrobial Peptide-levofloxacin Conjugate Against Resistant Bacteria: A Novel Approach to Combat Antimicrobial Resistance.
Journal: Current pharmaceutical biotechnology
Published: March 24, 2025
Enhancement of Fowlicidin-1's Therapeutic Efficacy: Mitigation of Toxicity via a Chitosan Cross-Linked Nanocarrier System.
Journal: Current pharmaceutical biotechnology
Published: March 02, 2025
Development of a novel ultrashort antimicrobial peptide-levofloxacin conjugate with enhanced synergistic activity against multidrug and levofloxacin-resistant bacterial isolates.
Journal: Research in pharmaceutical sciences
Published: September 19, 2024
Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: June 09, 2024
The design and evaluation of the antimicrobial activity of a novel conjugated penta-ultrashort antimicrobial peptide in combination with conventional antibiotics against sensitive and resistant strains of S. aureus and E. coli.
Journal: Research in pharmaceutical sciences
Published: February 25, 2022
Punicalagin and zinc (II) ions inhibit the activity of SARS-CoV-2 3CL-protease in vitro.
Journal: European review for medical and pharmacological sciences
Published: June 10, 2021
The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics.
Journal: Antibiotics (Basel, Switzerland)
Published: May 28, 2021
Immunodiagnosis of cattle fascioliasis using a 27 kDa Fasciola gigantica antigen.
Journal: Veterinary world
Published: April 13, 2021
Pretreatment with Salvadora persica L. (Miswak) aqueous extract alleviates paracetamol-induced hepatotoxicity, nephrotoxicity, and hematological toxicity in male mice.
Journal: Veterinary world
Published: October 02, 2020
Budget Impact Analysis of Switching to Rituximab's Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 17, 2020
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold.
Journal: Acta pharmaceutica (Zagreb, Croatia)
Published: March 21, 2020
Last Updated: 09/26/2026